Abstract
The concurrent diagnosis of breast cancer and pregnancy is a poignant clinical challenge. Historically, this situation has placed the welfare of the mother in conflict with that of the fetus. Because of the infrequent occurrence of simultaneous breast cancer and pregnancy, few clinicians have experience in providing information and support for the patient and her family. Often the first response is to recommend abortion. The literature about breast cancer during pregnancy is largely anecdotal, and no prospective analyses of a systematic approach to diagnosis and treatment have been reported. The two primary concerns are treatment of the mother’s breast cancer and the impact of treatment decisions on the fetus and the outcome of the pregnancy. For the physician, the major concern is providing adequate information for truly informed consent in an area of clinical medicine with few data. The fear and anxiety engendered by the unknown future necessitate especially careful, thoughtful, and empathic support to minimize suffering.1
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cassel EJ. The nature of suffering and the goals of medicine. N Engl J Med 1982;306:639–645.
White TT. Prognosis of breast cancer for pregnant and nursing women: analysis of 1,413 cases. Surg Gynecol Obstet 1955;700:661–666.
Lewiston EF. Breast cancer and pregnancy or lactation. Surg Gynecol Obstet 1954;99:417–424.
Crosby CH, Barclay T. Carcinoma of the breast: surgical management of patients with special conditions. Cancer 1971;28:1628–1636.
Noyes RD, Spanos WJ, Montague ED. Breast cancer in women aged 30 and under. Cancer 1982;49:1302–1307.
Ventura S. First births to older mothers. Am J Public Health 1989;79:1675–1684.
Kelsey J, Berkowitz G. Breast cancer epidemiology. Cancer Res 1988;48:5615–5623.
Usmani K, Moran EM, Haider W, et al. Breast cancer in pregnant and lactating women. J Environ Pathol Toxicol Oncol 1995;14:227–234.
Lethaby A, O’Neill M, Mason B, et al. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer 1996;67:751–755.
Anderson BO, Petrek JA, Byrd D, et al. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol 1996;3:204–211.
Collins J, Liao S, Wile A. Surgical management of breast masses in pregnant women. J Reprod Med 1995;40:785–788.
Ribeiro GG, Palmer M. Breast carcinoma associated with pregnancy: a clinician’s dilemma. BMJ 1977;2:1524–1527.
Byrd BF, Bayne DS, Robertson JC, et al. Treatment of breast tumors associated with pregnancy and lactation. Ann Surg 1962;155:940–947.
Slavin J, Billson V, Ostor A. Nodular breast lesions during pregnancy and lactation. Histopathology 1993;22:481–485.
Liberman L, Giess C, Dershaw D, et al. Imaging of pregnancy-associated breast cancer. Radiology 1994;191:245–248.
Gupta R, McHutchison A, Dowle C, et al. Fine-needle aspiration cytodiagnosis of breast masses in pregnant and lactating women and its impact on management. Diagn Cytopathol 1993;9:156–159.
Baker J, Ali A, Groch MW, et al. Bone scanning in pregnant patients with breast carcinoma. Clin Nucl Med 1987;12:519–524.
Mahfouz AE, Hamm B, Mathieu D. Imaging of metastases to the liver. Eur Radiol 1996;6:607–614.
Lee MG, Baker ME, Sostman HD, et al. The diagnostic accuracy/efficacy of MRI in differentiating hepatic hemangiomas from metastatic colorectal/breast carcinoma: a multiple reader ROC analysis using a jackknife technique. J Comput Assist Tomogr 1996;20:905–913.
Delorme S, van Kaick G. Imaging of abdominal nodal spread in malignant disease. Eur Radiology 1996;6:262–274.
Larson RE, Semelka RC. Magnetic resonance imaging of the liver. Top Magn Reson Imaging 1995;7:71–81.
Flickinger FW, Sanal SM. Bone marrow MRI: techniques and accuracy for detecting breast cancer metastases. Magn Reson Imaging 1994;12:829–835.
Sanai SM, Flickinger FW, Caudell MJ, et al. Detection of bone marrow involvement in breast cancer with magnetic resonance imaging. J Clin Oncol 1994;12:1415–1421.
Kirkinen P, Partanen K, Vainio P, Ryynanen M. MRI in obstetrics: a supplementary method for ultrasonography. Ann Med 1996;28:131–136.
Beauchamp NA, Kuhlman JE. MR appearance of placental site gestational trophoblastic neoplasm. Clin Imaging 1996;20:60–63.
Duncan KR. The development of magnetic resonance imaging in obstetrics. Br J Hosp Med 1996;55:178–181.
LaBan MM, Rapp NS, von Oeyen P, et al. The lumbar herniated disk of pregnancy: a report of six cases identified by magnetic resonance imaging. Arch Phys Med Rehabil 1995;76:476–479.
Eltorby M, Khane V, Osborne P, et al. Placental metastasis from maternal carcinoma: a report of three cases. J Reprod Med 1995;40:399–403.
Tobon H, Horowitz LF. Breast cancer during pregnancy. Breast Dis 1993;6:127–134.
Jackisch C, Schwenkhagen A, Louwen F, et al. Breast cancer in pregnancy [abstract]. Proc Am Soc Clin Oncol 1995;14:132.
Elledge R, Ciocca DR, Langone G, et al. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancer from pregnant patients. Cancer 1993;71:2499–2506.
Mazze R, Kallen B. Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol 1989;161:1178–1185.
Pedersen H, Finster M. Anesthetic risk in the pregnant surgical patient. Anesthesiology 1979;51:439–451.
Van der Vange N, van Dongen JA. Breast cancer and pregnancy. Eur J Surg Oncol 1991;17:1–8.
Brent RL. The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol 1989;16:347–368.
Wiebe V, Sipila P. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 1994;16:75–112.
Arceci RJ, Croop JM, Horwitz SB, et al. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci USA 1988;85:4350–4354.
Karp GI, von Oeyen P, Valone F, et al. Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep 1983;67:773–777.
Berry DL, Holmes FA, Parisi VM, et al. Treatment protocol for breast cancer in pregnancy [abstract]. In: 9th International Congress on Breast Diseases, 1996;217.
Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989;16:337–346.
Zemlickis D, Lishnen M, Dogendorfer P, et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992;152:573–576.
Ezzat A, Raja MA, Berry J, et al. Impact of pregnancy on non-metastatic breast cancer: a case control study. Clin Oncol (R Coll Radiol) 1996;8:367–370.
Sutton R, Buzdar AU, Hortobagyi GN. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer 1990;65:847–850.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Theriault, R.L. (1999). Breast Cancer During Pregnancy. In: Singletary, S.E. (eds) Breast Cancer. M.D. Anderson Solid Tumor Oncology Series. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2146-3_19
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2146-3_19
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7432-2
Online ISBN: 978-1-4612-2146-3
eBook Packages: Springer Book Archive